
Conference Coverage
about 17 hours ago
CAVIAR: Alirocumab Safely Lowers Cholesterol After Heart Transplantabout 19 hours ago
Tirzepatide’s Dual Approach Better for MACE, HF: Stephen Nicholls, MBBSabout 22 hours ago
Integrated Care for Patients With Kidney and CV Risks: Roy Mathew, MDabout 24 hours ago
POLY-HF: Polypill Boosts Heart Function, Adherence in Heart FailureLatest Content

Five Ways AI Is Transforming Cancer Care—and Companies That Are Making It Happen

Bridging the Gap: Implementing Bispecific Antibodies for Multiple Myeloma Across Care Setting

Assessing New York’s Health Care Disparities Using Health Plan Quality Data

FDA to Remove Black Box Warnings From HRT, Debate Ensues

CAVIAR: Alirocumab Safely Lowers Cholesterol After Heart Transplant

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

New findings reveal high rates of depression, anxiety, and sleep issues in individuals with psoriatic arthritis and palmoplantar psoriasis.

In this investigation, the authors evaluated the impact of a voluntary transition to risk-based contracts under Medicare Advantage on health care use.

A white paper explores how biomarker testing enhances patient outcomes and what barriers prevent access several common cancers.

Higher dietary fiber intake was associated with a reduced risk of moderate to severe diarrhea up to 2 years after diagnosis.

Combining 3 standard therapies into a single pill improved outcomes for adults with heart failure with reduced ejection fraction.

New research suggests stress cardiac MRI could help diagnose angina and improve quality of life for patients whose arteries appear clear on angiography.

Eosinophilia serves as a significant biomarker for predicting immune-related adverse events in NSCLC patients treated with immune checkpoint inhibitors.

Only 4% of NIH prevention projects target health disparities, revealing a major gap between equity research and real-world implementation.

Experts discuss the urgent need for equitable access to cancer care, addressing barriers in treatment delivery and the importance of personalized medicine.

Experts discuss the intersection of innovation, affordability, and access in cancer care, focusing on multiple myeloma and NSCLC advancements.































































